CN115974702A - Spiro compound and application thereof - Google Patents

Spiro compound and application thereof Download PDF

Info

Publication number
CN115974702A
CN115974702A CN202310114497.9A CN202310114497A CN115974702A CN 115974702 A CN115974702 A CN 115974702A CN 202310114497 A CN202310114497 A CN 202310114497A CN 115974702 A CN115974702 A CN 115974702A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
group
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202310114497.9A
Other languages
Chinese (zh)
Other versions
CN115974702B (en
Inventor
陈少福
白科研
戴雷
蔡丽菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Aglaia Optoelectronic Materials Co Ltd
Original Assignee
Guangdong Aglaia Optoelectronic Materials Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Aglaia Optoelectronic Materials Co Ltd filed Critical Guangdong Aglaia Optoelectronic Materials Co Ltd
Publication of CN115974702A publication Critical patent/CN115974702A/en
Application granted granted Critical
Publication of CN115974702B publication Critical patent/CN115974702B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The spiro compound of the present invention has a structure represented by formula (1). The spiro compound provided by the invention has the advantages of high optical and electrical stability, low sublimation temperature, low driving voltage, small carrier transverse mobility, high luminous efficiency, long service life of devices and the like, and can be used for organicIn an electroluminescent device. Meanwhile, the material has a lower melting point, and is favorable for the evaporation stability of the material when being used as a melting type material. The compound is used as a hole injection and transport material and has the possibility of being applied to the AMOLED industry.

Description

Spiro compound and application thereof
Technical Field
The invention relates to the technical field of organic electroluminescence, in particular to an organic luminescent material suitable for an organic electroluminescent device, and particularly relates to a spiro compound and application thereof.
Background
At present, organic electroluminescent devices (OLEDs), which are a new generation of display technology, are receiving more and more attention in display and lighting technologies, and have a wide application prospect. However, the performance of OLED devices, such as light emission efficiency, driving voltage, and lifetime, is still in need of further enhancement and improvement compared to market application requirements.
Generally, the OLED device has a basic structure in which various organic functional material thin films with different functions are sandwiched between metal electrodes, as a sandwich structure, and holes and electrons are respectively injected from a cathode and an anode under the driving of current, and after the holes and the electrons move for a certain distance, they are recombined in a light emitting layer and released in the form of light or heat, thereby generating light emission of the OLED. However, the organic functional material is a core component of the organic electroluminescent device, and the thermal stability, photochemical stability, electrochemical stability, quantum yield, film forming stability, crystallinity, color saturation and the like of the material are main factors influencing the performance of the device.
In order to obtain an organic light emitting device with excellent performance, the selection of materials is important, and the materials not only comprise an emitter material which plays a role in light emission, but also comprise functional materials such as a hole injection material, a hole transport material, a host material, an electron transport material, an electron injection material and the like which are mainly used for carrier injection and transport in the device, and the selection and optimization of the materials can improve the transport efficiency of holes and electrons, balance the holes and the electrons in the device, and further improve the voltage, the light emitting efficiency and the service life of the device.
Patent document 1 (CN 103108859B) describes
Figure BDA0004078030810000011
The spirofluorene arylamine structure is used as a hole transport material, the material provides better device performance, but the service life of the device, particularly the service life of a blue light-emitting device, is required to be further improved, and the transverse hole mobility of the material is required to be further improved so as to provide better low gray scale color purity of an OLED product; patent document 2 (CN 103641726B) describes->
Figure BDA0004078030810000012
The spirofluorene arylamine structure is used as a second hole transport material, and the device performance of the material needs to be greatly improved, particularly the device efficiency; patent document 3 (CN 111548278A) describes->
Figure BDA0004078030810000021
The arylamine of the spirofluorene arylamine contains substituent groups such as alkyl, deuterium, cycloalkyl and other structures which are used as hole transport materials, the device performance of the materials is to be further improved, and particularly the service life of the devices is prolonged; patent document 4 (CN 114835591A) describes->
Figure BDA0004078030810000022
The device performance of the arylamine hole transport material containing the unilateral cycloalkyl substituted diphenylfluorene is to be further improved, particularly the device efficiency, and meanwhile, the reported compound has higher melting point and is not suitable for being applied to the industry as a molten material. Patent document 5 (CN 112110825B) describes
Figure BDA0004078030810000023
The structure takes adamantyl fluorene as a core structure, and does not have the core spirofluorene structureThe same is true. Patent document 6 (CN 107459466B) describes & -bamboo>
Figure BDA0004078030810000024
The diphenylfluorene structure, also in terms of efficiency and lifetime, is yet to be improved.
Disclosure of Invention
The present invention has been made to solve the above-mentioned drawbacks, and an object of the present invention is to provide a high-performance organic electroluminescent device and a spiro compound material that can realize such an organic electroluminescent device.
The spiro compound of the present invention has a structure represented by formula (1). The spiro compound provided by the invention has the advantages of high optical and electrical stability, low sublimation temperature, low driving voltage, small carrier transverse mobility, high luminous efficiency, long service life of devices and the like, and can be used in organic electroluminescent devices. Meanwhile, the material has a lower melting point, and is favorable for the evaporation stability of the material when being used as a melting type material. The compound is used as a hole injection and transport material and has the possibility of being applied to the AMOLED industry.
A spiro compound having a structure represented by the formula (1),
Figure BDA0004078030810000025
wherein, R is 1 ,R 2 Is substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl;
wherein, the ring A is selected from substituted or unsubstituted C3-C20 saturated fat rings
Wherein R is a -R d Is a substituent on the benzene ring independently selected from deuterium, halogen, cyano, hydroxyl, mercapto, amine, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl, substituted or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C6-C30 aryl, mercapto, amino, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl, substituted or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C6-C30 aryl, mercapto, or a pharmaceutically acceptable salt thereof,Substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted tri-C1-C10 alkylsilyl, substituted or unsubstituted tri-C6-C12 arylsilyl, substituted or unsubstituted di-C1-C10 alkyl-mono-C6-C30 arylsilyl, substituted or unsubstituted mono-C1-C10 alkyl-di-C6-C30 arylsilyl, or two adjacent groups may be connected to each other to form an aliphatic ring or an aromatic ring structure;
wherein L is 1 、L 2 、L 3 Independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C2-C30 heteroarylene;
wherein Ar is independently selected from substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl;
wherein m, n, p, q are independently selected from 0 or an integer of 1-4;
wherein at least one of the heteroalkyl, heterocycloalkyl, and heteroaryl groups contains a O, N or S heteroatom;
the substitution is by deuterium, halogen, C1-C6 alkyl, C3-C6 cycloalkyl, C6-C10 aryl, C1-C4 alkyl substituted C6-C10 aryl, C1-C6 alkyl substituted amino, cyano, isonitrile, or phosphino, wherein the number of substitutions is from mono to maximum number of substitutions.
As a preferred spiro compound, which is one of the structures represented by the formulae (2) to (5),
Figure BDA0004078030810000031
wherein the definitions of the rest symbols are the same as the above.
A preferred spiro compound is a compound having a structure represented by the formula (2) or (3), R 1 And R 2 The same or different.
As preferred spiro compounds, L is represented by the following formula (2) to formula (5) 1 、L 2 、L 3 Preferably a single bond.
Preferred spiro compounds are those having the structures represented by formulas (6) to (9):
Figure BDA0004078030810000041
as preferred spirocyclic compounds, wherein ring a in said spirocyclic compound is one of the following aliphatic rings:
Figure BDA0004078030810000042
as preferred spiro compounds, R 1 And R 2 And Ar is selected from substituted or unsubstituted phenyl, biphenyl, naphthyl, fluorenyl, dibenzofuranyl or carbazolyl, wherein the substitution is by deuterium, F, cl, br, C6-C10 aryl, C1-C6 alkyl, C3-C6 cycloalkyl.
Said R is 1 ,R 2 Is substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C3-C20 cycloalkyl.
Preferred spiro compounds are those of one of the formulae below, or the corresponding partially or completely deuterated or fluorinated,
Figure BDA0004078030810000043
/>
Figure BDA0004078030810000051
/>
Figure BDA0004078030810000061
/>
Figure BDA0004078030810000071
Figure BDA0004078030810000081
the invention also relates to the use of the spiro compounds in organic electroluminescent devices.
It is another object of the present invention to provide the spiro compound as a hole injection layer and/or a hole transport layer of an organic electroluminescent device.
The material of the invention has the advantages of high optical and electrical stability, low sublimation temperature, low driving voltage, small carrier transverse mobility, high luminous efficiency, long service life of the device and the like, and can be used in organic electroluminescent devices. In particular, the material can be used as a hole injection and transport material in the AMOLED industry.
Drawings
FIG. 1 shows the reaction of compound CPD004 of the present invention in deuterated chloroform solution 1 An HNMR spectrogram,
FIG. 1 shows the reaction of the compound CPD017 of the present invention in deuterated chloroform solution 1 HNMR spectrogram
Detailed Description
The compound of the present invention, a spiro compound, has a structure represented by formula (1),
Figure BDA0004078030810000082
wherein, R is 1 ,R 2 Is substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl;
wherein, the ring A is selected from substituted or unsubstituted C3-C20 saturated fat rings
Wherein R is a -R d Independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, hydroxyl, mercapto, amine, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl, substituted or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted tri-C1-C10 alkylsilyl, substituted or unsubstituted tri-C6-C12 arylsilylA silyl group, a substituted or unsubstituted diC 1-C10 alkyl-mono C6-C30 arylsilyl group, a substituted or unsubstituted mono C1-C10 alkyl-di C6-C30 arylsilyl group, or two adjacent groups may be linked to each other to form an aliphatic or aromatic cyclic structure;
wherein L is 1 、L 2 、L 3 Independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C2-C30 heteroarylene;
wherein Ar is independently selected from substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl;
wherein m, n, p, q are independently selected from 0 or an integer of 1-4;
wherein the heteroalkyl and heteroaryl groups contain at least one O, N or S heteroatom;
the substitution is by deuterium, F, cl, br, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 alkyl substituted amino, cyano, isonitrile or phosphino, wherein the number of substitutions is from mono-to maximum number of substitutions.
Examples of the groups of the compound represented by the formula (1) will be described below.
In the present specification, "carbon number a to b" in the expression "X group having a to b carbon number which is substituted or unsubstituted" indicates the carbon number in the case where the X group is unsubstituted, and does not include the carbon number of the substituent when the X group is substituted.
The alkyl group having 1 to 10 carbon atoms is a linear or branched alkyl group, specifically, a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group and isomers thereof, an n-hexyl group and isomers thereof, an n-heptyl group and isomers thereof, an n-octyl group and isomers thereof, an n-nonyl group and isomers thereof, an n-decyl group and isomers thereof, etc., preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and more preferably a propyl group, an isopropyl group, an isobutyl group, a sec-butyl group, and a tert-butyl group.
Examples of the C3-C20 cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl and the like, and cyclopentyl and cyclohexyl are preferred.
Examples of the alkenyl group having 2 to 10 carbon atoms include a vinyl group, a propenyl group, an allyl group, a 1-butadienyl group, a 2-butadienyl group, a 1-hexatrienyl group, a 2-hexatrienyl group, and a 3-hexatrienyl group, and a propenyl group and an allyl group are preferable.
The C1-C10 heteroalkyl group is a linear or branched alkyl group or cycloalkyl group containing an atom other than carbon and hydrogen, and examples thereof include mercaptomethylmethane group, methoxymethane group, ethoxymethane group, tert-butoxymethane group, N-dimethylmethane group, epoxybutane group, epoxypentane group, epoxyhexane group and the like, with methoxymethane group and epoxypentane group being preferred.
Specific examples of the aryl group include a phenyl group, a naphthyl group, an anthracenyl group, a phenanthryl group, a tetracenyl group, a pyrenyl group, a chrysenyl group, a benzo [ c ] phenanthryl group, a benzo [ g ] chrysyl group, a fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a biphenyl group, a terphenyl group, a quaterphenyl group, a fluoranthenyl group and the like, and a phenyl group and a naphthyl group are preferable.
Specific examples of the heteroaryl group include a pyrrolyl group, a pyrazinyl group, a pyridyl group, a pyrimidinyl group, a triazinyl group, an indolyl group, an isoindolyl group, an imidazolyl group, a furyl group, a benzofuryl group, an isobenzofuryl group, a dibenzofuryl group, a dibenzothienyl group, an azabenzofuryl group, an azabenzothienyl group, a diazdibenzofuryl group, a diazdibenzothienyl group, a quinolyl group, an isoquinolyl group, a quinoxalinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a phenothiazinyl group, a phenoxazinyl group, an oxazolinyl group, an oxadiazolyl group, a furazanyl group, a thienyl group, a benzothienyl group, a dihydroacridinyl group, an azacarbazolyl group, a diazacarbozolyl group, and the like, and preferably a pyridyl group, a pyrimidinyl group, a triazinyl group, a dibenzofuryl group, a dibenzothienyl group, an azabenzofuranyl group, a diazabenzodibenzothienyl group, a carbazolyl group, an azacarbazolyl group and the like.
The following examples are merely for the convenience of understanding the technical invention and should not be construed as specifically limiting the invention.
The raw materials and solvents involved in the synthesis of the compounds of the present invention are commercially available from suppliers well known to those skilled in the art, such as Alfa, acros, and the like.
EXAMPLE 1 Synthesis of Compound CPD003
Figure BDA0004078030810000101
Synthesis of Compound CPD003-3
Compounds CPD003-1 (20.00g, 66.84mmol), CPD003-2 (12.44g, 73.53mmol), tris (dibenzylideneacetone) dipalladium (1.84g, 2.01mmol), 2-dicyclohexylphosphine-2 ',4',6' -triisopropylbiphenyl (6.37g, 13.37mmol), sodium tert-butoxide (9.63g, 100.26mmol) and dry toluene (300 ml) were placed in a 1000ml three-necked round-bottomed flask, purged with nitrogen three times, warmed to 100 ℃ and reacted for 3 hours. TLC (ethyl acetate: n-hexane =1 = 20 as developing solvent) monitored the complete consumption of the starting material CPD 003-1.
After cooling to room temperature, toluene (400 ml) was added, washed with deionized water (3 × 200ml), separated, purified by silica gel column chromatography (200-300 mesh silica gel, ethyl acetate: n-hexane =1, 25 as eluent), and after elution, concentrated at 60 ℃ under reduced pressure to obtain CPD003-3 as a white solid (22.03 g, purity: 99.77%, yield: 85.06%), mass spectrum: 388.22 (M + H).
Synthesis of Compound CPD003
CPD003-4 (23.00g, 45.31mmol), CPD003-3 (17.91g, 46.22mmol), tris (dibenzylideneacetone) dipalladium (0.83g, 0.91mmol), 50% by mass of a toluene solution of tri-tert-butylphosphine (3.67g, 9.06mmol), sodium tert-butoxide (6.53g, 67.97mmol) and dry toluene (350 ml) were charged in a 1000ml three-necked round-bottomed flask, nitrogen was replaced three times with stirring at room temperature, followed by heating to 110 ℃ for 4 hours, and the reaction was monitored by TLC (ethyl acetate: n-hexane =1 20 as a developing agent) and the starting material CPD003-4 was consumed.
Cooling to room temperature, adding toluene (400 ml), washing with deionized water (3 × 300ml), separating, purifying by silica gel column chromatography (200-300 mesh silica gel, ethyl acetate: n-hexane =1:15 as eluent), eluting, and concentrating under reduced pressure at 70 ℃ to obtain a white solid; 150ml of methanol was added, slurried at 65 ℃ for 1 hour, filtered, the cake was rinsed with 50ml of methanol, and dried under vacuum at 90 ℃ for 8 hours to give CPD003 (27.79 g, purity: 99.90%, yield: 75.34%) as a white solid. Sublimation purification of 27.79g of crude CPD003 afforded sublimation pure CPD003 (22.51 g, purity: 99.95%, yield: 81.00%), ms spectrum: 814.24 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.72-7.67(m,1H),7.55-7.47(m,3H),7.44(d,J=10.0Hz,2H),7.39(s,1H),7.24(d,J=3.1Hz,2H),7.15-7.11(m,1H),7.07-6.90(m,13H),6.86-6.80(m,2H),6.76-6.65(m,3H),6.63-6.59(m,1H),1.87-1.78(m,2H),1.67-1.59(m,2H),1.42-1.38(m,4H),1.20(s,18H).
EXAMPLE 2 Synthesis of Compound CPD004
Figure BDA0004078030810000111
Synthesis of Compound CPD004-2
Referring to the synthesis and purification method of the compound CPD003-3, the target compound CPD004-2 (23.24 g, purity: 99.71%, yield: 81.01%) can be obtained by changing the corresponding raw material: 402.22 (M + H).
Synthesis of Compound CPD004
Referring to the synthesis and purification method of the compound CPD003, the white solid was the objective compound CPD004 (16.34 g, purity: 99.92%, yield: 75.63%) by changing the corresponding starting material. Sublimation purification of 16.34g of crude CPD004 yielded sublimed pure CPD004 (12.51 g, purity: 99.93%, yield: 76.56%), ms spectrum: 828.46 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.72(d,J=7.5Hz,1H),7.60-7.53(m,4H),7.49(d,J=7.5Hz,1H),7.33-7.13(m,10H),7.03-6.92(m,7H),6.79(s,1H),6.73(s,2H),6.63(d,J=7.5Hz,1H),6.57(d,J=8.4Hz,1H),6.44(s,1H),1.74-1.57(m,5H),1.49-1.38(m,5H),1.21(s,18H).
EXAMPLE 3 Synthesis of Compound CPD014
Figure BDA0004078030810000112
Synthesis of Compound CPD014
According to the synthesis and purification method of the compound CPD003, the desired compound CPD014 (18.05 g, purity: 99.92%, yield: 73.06%) was obtained as a white solid by simply changing the corresponding starting material. Sublimation purification of 18.05g of crude CPD014 yielded sublimed pure CPD014 (14.44 g, purity: 99.92%, yield: 80.00%), ms spectrum: 838.16 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.73-7.69(m,1H),7.53-7.52(m,2H),7.50-7.46(m,9.1Hz,3H),7.16(d,J=3.1Hz,2H),7.11-6.91(m,13H),6.89-6.86(m,5H),6.79-6.65(m,3H),2.58-2.32(m,2H),2.04-1.69(m,4H),1.69-1.46(m,4H),1.45-1.26(m,16H).
EXAMPLE 4 Synthesis of the Compound CPD017
Figure BDA0004078030810000121
Synthesis of Compound CPD017
Referring to the synthesis and purification method of the compound CPD003, only the corresponding raw materials were changed to obtain the desired compound CPD017 as a white solid (14.21 g, purity: 99.93%, yield: 76.06%). Sublimation and purification of 14.21g of crude CPD017 product gave pure CPD017 (10.13 g, purity: 99.94%, yield: 71.28%) by mass spectrometry: 854.26 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.69(d,J=7.5Hz,1H),7.57-7.48(m,5H),7.30-6.86(m,18H),6.62-6.57(m,4H),6.42(s,1H),1.98(m,4H),1.73-1.26(m,22H).
EXAMPLE 5 Synthesis of Compound CPD029
Figure BDA0004078030810000122
Synthesis of Compound CPD029-2
Referring to the synthesis and purification method of the compound CPD003-3, only the corresponding raw materials need to be changed, and the target compound CPD029-2 (20.87 g, purity: 99.88%, yield: 74.41%) is obtained, and mass spectrum: 402.22 (M + H).
Synthesis of Compound CPD029
Referring to the synthesis and purification method of the compound CPD003, the white solid was the objective compound CPD029 (17.86 g, purity: 99.91%, yield: 70.11%) by changing the corresponding raw material. Sublimation purification of 17.86g crude CPD029 gave pure CPD029 (14.55 g, purity: 99.92%, yield: 81.46%) as mass spec: 828.14 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.70-7.65(m,1H),7.51-7.44(m,3H),7.44-7.36(m,3H),7.23(d,J=3.1Hz,2H),7.13-7.05(m,3H),7.03-6.87(m,8H),6.86-6.78(m,3H),6.78-6.68(m,4H),6.63-6.59(m,1H),2.34(s,3H),1.88-1.74(m,4H),1.63-1.58(m,4H),1.27(s,18H).
EXAMPLE 6 Synthesis of Compound CPD038
Figure BDA0004078030810000131
Synthesis of Compound CPD038-2
According to the synthesis and purification method of the compound CPD003-3, the target compound CPD038-2 (20.87 g, purity: 99.73%, yield: 70.51%) can be obtained by only changing the corresponding raw material: 428.23 (M + H).
Synthesis of Compound CPD038
Referring to the synthesis and purification method of the compound CPD003, the desired compound CPD038 (14.16 g, purity: 99.92%, yield: 70.01%) was obtained as a white solid by simply changing the corresponding starting material. Sublimation purification of 14.16g of crude CPD038 gave sublimation-purified CPD038 (11.03 g, purity: 99.93%, yield: 77.89%), ms: 878.26 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.72-7.62(m,8H),7.41(d,J=2.9Hz,2H),7.36-7.21(m,6H),7.18-7.08(m,4H),7.08-6.94(m,7H),2.56(s,2H),2.24-1.68(m,8H),1.64-1.32(m,16H),1.00(s,6H).
EXAMPLE 7 Synthesis of Compound CPD048
Figure BDA0004078030810000132
Synthesis of Compound CPD048
Referring to the synthesis and purification method of the compound CPD003, the white solid was obtained as the objective compound CPD048 (20.55 g, purity: 99.94%, yield: 77.41%) by changing the corresponding raw material. Sublimation purification of 20.55g of crude CPD048 gave pure CPD048 (14.58 g, purity: 99.94%, yield: 70.94%), MS: 856.16 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.72-7.66(m,1H),7.53-7.45(m,3H),7.45-7.37(m,3H),7.21(s,2H),7.11-6.88(m,13H),6.88-6.62(m,7H),1.73-1.54(m,9H),1.49-1.36(m,5H)1.12(s,18H).
EXAMPLE 8 Synthesis of Compound CPD050
Figure BDA0004078030810000141
Synthesis of Compound CPD050
Referring to the synthesis and purification method of the compound CPD003, the white solid was obtained as the objective compound CPD050 (17.63 g, purity: 99.91%, yield: 69.83%) by changing the corresponding raw materials. 17.63g crude CPD050 was purified by sublimation to give pure sublimated CPD050 (13.03 g, purity: 99.93%, yield: 73.90%), ms spectrum: 828.46 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.73-7.64(m,1H),7.51(d,J=3.2Hz,1H),7.49-7.37(m,4H),7.25-7.14(m,4H),7.07-6.89(m,10H),6.89-6.60(m,9H),1.74-1.53(m,2H),1.48-1.46(m,3H),1.41-1.36(m,5H),1.20(s,18H).
EXAMPLE 9 Synthesis of Compound CPD059
Figure BDA0004078030810000142
Synthesis of Compound CPD059-2
Referring to the synthesis and purification method of the compound CPD003-3, the target compound CPD059-2 (18.01 g, purity: 99.59%, yield: 80.00%) was obtained by changing the corresponding raw material: 484.22 (M + H).
Synthesis of Compound CPD059
Referring to the synthesis and purification method of the compound CPD003, the desired compound CPD059 (17.56 g, purity: 99.91%, yield: 79.77%) was obtained as a white solid by simply changing the corresponding starting materials. Sublimation purification of 17.56g of crude CPD059 yielded sublimed pure CPD059 (12.97 g, purity: 99.93%, yield: 73.86%) as mass spectrum: 910.23 (M + H).
1 H NMR(400MHz,CDCl 3 )7.71-7.64(m,1H),7.52-7.44(m,3H),7.44-7.36(m,3H),7.25(d,J=2.9Hz,2H),7.18-7.07(m,6H),7.06-6.88(m,8H),6.88-6.78(m,3H),6.78-6.64(m,2H),2.53-2.50(m,1H),1.71-1.49(m,10H),1.49-1.38(m,10H),1.22(s,18H).
EXAMPLE 10 Synthesis of Compound CPD071
Figure BDA0004078030810000151
Synthesis of Compound CPD071-2
According to the synthesis and purification method of the reference compound CPD003-3, only the corresponding raw materials are changed to obtain the target compound CPD071-2 (17.77 g, purity: 99.81%, yield: 80.20%), and mass spectrum: 491.20 (M + H).
Synthesis of Compound CPD071
Referring to the synthesis and purification method of the compound CPD003, the white solid was the objective compound CPD071 (16.58 g, purity: 99.92%, yield: 77.63%) by changing the corresponding raw material. Sublimation purification of 16.58g of crude CPD071 yielded sublimed pure CPD071 (11.58 g, purity: 99.93%, yield: 69.84%), ms spectrum: 917.42 (M + H).
1 H NMR(400MHz,CDCl 3 )δ8.08(d,J=7.7Hz,2H),7.72(d,J=3.3Hz,1H),7.43-7.39(m,2H),7.39-7.30(m,3H),7.20(d,J=3.1Hz,2H),7.19-6.95(m,11H),6.94-6.84(m,4H),6.82-6.71(m,5H),6.70-6.62(m,2H),1.71-1.56(m,4H),1.47-1.40(m,6H),1.20(s,18H).
Example 11 Synthesis of Compound CPD075
Figure BDA0004078030810000152
Synthesis of Compound CPD075-2
The compounds CPD003-4 (20.00g, 39.41mmol), CPD075-1 (6.78g, 43.35mmol), dichlorodi-tert-butyl- (4-dimethylaminophenyl) phosphorus palladium (II) (0.56g, 0.79mmol), potassium carbonate (10.89g, 78.82mmol), tetrahydrofuran (300 ml) and deionized water (100 ml) were charged into a 1000ml three-necked round bottom flask, purged with nitrogen three times, warmed to 65 ℃ and reacted for 4 hours. TLC (ethyl acetate: n-hexane =1 = 20 as developing solvent) monitored the complete consumption of the starting material CPD 003-4.
The temperature was reduced to 50 ℃, tetrahydrofuran was removed by concentration under reduced pressure, ethyl acetate (800 ml) was added, washed with deionized water (3 × 350ml), the liquid was separated, purified by silica gel column chromatography (200-300 mesh silica gel, ethyl acetate: n-hexane =1:30 as eluent), and after elution, concentrated under reduced pressure at 60 ℃ to give CPD075-2 as a white solid (16.75 g, purity: 99.61%, yield: 78.85%), mass spectrum: 539.12 (M + H).
Synthesis of Compound CPD075
Referring to the synthesis and purification method of the compound CPD003, the reaction was carried out at 130 ℃ for 5 hours with the corresponding raw material changed to xylene as a reaction solvent, to obtain the desired compound CPD075 as a white solid (13.05 g, purity: 99.94%, yield: 74.22%). Sublimation purification of 13.05g of crude CPD075 product gave pure CPD075 (10.01 g, purity: 99.94%, yield: 76.70%) as mass spectrum: 890.20 (M + H).
1 H NMR(400MHz,CDCl 3 )δ7.72 -7.67(m,2H),7.58(d,J=2.9Hz,1H),7.54-7.44(m,3H),7.43-7.34(m,3H),7.21(d,J=3.1Hz,2H),7.19-7.11(m,2H),7.07-6.89(m,10H),6.89-6.71(m,8H),6.68-6.66(m,2H),1.82-1.75(m,2H),1.68-1.60(m,2H),1.49-1.41(m,4H),1.21(s,18H).
Application example: fabrication of organic electroluminescent devices
A 50mm x 1.0mm glass substrate with an ITO (100 nm) transparent electrode was ultrasonically cleaned in ethanol for 10 minutes, dried at 150 degrees and then subjected to N2 Plasma treatment for 30 minutes. The washed glass substrate was mounted on a substrate holder of a vacuum evaporation apparatus, and first, a compound HATCN was evaporated on the surface on the side of the transparent electrode line so as to cover the transparent electrode, thereby forming a thin film having a thickness of 5nm, then, an HTM1 was evaporated, thereby forming a thin film having a thickness of 60nm as an HTL1, and then, an HTM2 was evaporated on the HTM1 thin film, thereby forming a thin film having a thickness of 10nm as an HTL2, and then, a host material and a dopant material were evaporated on the HTM2 thin film in a co-evaporation mode (ratio 98%: 2%) to form a thin film having a thickness of 25nm. On the light-emitting layer, HBL (5 nm) as a hole blocking layer material and ETL (30 nm) as an electron transport material were sequentially evaporated according to the following formulation, and then LiQ (1 nm) as an electron injection material was evaporated on the electron transport material layer, and then Mg/Ag (100nm, 1).
Figure BDA0004078030810000161
Figure BDA0004078030810000171
Evaluation:
the devices were subjected to device performance tests, and the compounds of examples of the present invention and comparative examples 1 to 3 were compared as HTL layers, respectively, and the luminescence spectrum was tested using a system of both spectral radiation (CS 2000) using a constant current power supply (Keithley 2400) and a fixed current density flowing through the light emitting element. At the same time, the current density is 20mA/cm 2 Next, the device voltage value, the current efficiency, and the time (LT 90) at which the test luminance was 90% of the initial luminance were measured. The results are as followsTable 1:
Figure BDA0004078030810000172
comparison of sublimation temperature: the sublimation temperature is defined as: the evaporation rate was 1 angstrom per second at a temperature corresponding to a degree of vacuum of 10-7 Torr. The test results were as follows:
material Sublimation temperature/. Degree.C
CPD003 264
CPD014 263
CPD017 266
CPD029 265
CPD050 267
Comparative Compound 1 268
Comparative Compound 2 268
Comparative Compound 3 265
Comparative Compound 4 275
HTM1 380
HTM2 275
As can be seen from the comparison of the data in the above table, the hole transport material of the present invention has a lower sublimation temperature, which is advantageous for industrial applications.
Comparison of carrier lateral mobility:
a 50mm x 1.0mm glass substrate is transformed into a glass substrate with ITO (100 nm) transparent electrodes and Mg/Ag (100nm, 1 2 Plasma treatment for 30 min. The washed glass substrate was mounted on a substrate holder of a vacuum evaporation apparatus, and first, an HTL1 layer having a thickness of 10nm was evaporated on a surface having a transparent electrode in such a manner as to cover the transparent electrode (3% HATCN was doped in CPD014, CPD017, comparative 1-3 compounds, and HTM1, respectively), and then an HTL2 layer having a thickness of 100nm was evaporated (CPD 014, CPD017, comparative 1-3 compounds, and HTM1, respectively), and voltage-current curves thereof were measured after encapsulation to obtain transverse transmission current data, and transverse resistance values ratios of the respective materials were obtained by calculation (calculated with comparative compound 1 as 100%). It can be observed that when the test voltage is 15v, the lateral resistance values of CPD014 and CPD017 are higher, both higher than those of comparative compounds 1-3 and HTM1, indicating that the lateral mobility of the carriers is small, the lateral crosstalk current is small, and the good low gray scale color purity is facilitated.
HTL1 HTL2 Transverse resistance ratio (%)
3%HATCN:97%CPD014 CPD014 355%
3%HATCN:97%CPD017 CPD017 271%
3% of HATCN:97% comparison 1 Comparative example 1 100%
3% of HATCN:97% comparison 2 Comparative example 2 97%
3% of HATCN:97% comparison 3 Comparison No. 3 99%
3% of HATCN:97% comparison 4 Comparative example 4 95%
3%HATCN:97%HTM1 HTM1 69%
The material of the invention has the advantages of high optical and electrical stability, low sublimation temperature, low driving voltage, small carrier transverse mobility, high luminous efficiency, long service life of the device and the like, and can be used in organic electroluminescent devices. In particular, the material can be used as a hole injection and transport material in the AMOLED industry.

Claims (11)

1. A spiro compound having a structure represented by the formula (1),
Figure FDA0004078030800000011
wherein, R is 1 ,R 2 Is substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl;
wherein, the ring A is selected from substituted or unsubstituted saturated fat rings of C3-C20;
wherein R is a -R d Is a substituent on the benzene ring, independently selected from deuterium, halogen, cyano, hydroxyl, mercapto, amine, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C3-C20 heterocycloalkyl, substituted or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted tri C1-C10 alkylsilyl, substituted or unsubstituted tri C6-C12 arylsilyl, substituted or unsubstituted di C1-C10 alkyl-C6-C30 arylsilyl, substituted or unsubstituted mono C1-C10 alkyl-di C6-C30 arylsilyl, or two adjacent groups may be linked to each other to form an aliphatic or aromatic ring structure;
wherein L is 1 、L 2 、L 3 Independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C2-C30 heteroarylene;
wherein Ar is independently selected from substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl;
wherein m, n, p, q are independently selected from 0 or an integer of 1-4;
wherein the heteroalkyl, heterocycloalkyl, and heteroaryl contain at least one O, N or S heteroatom;
the substitution is by deuterium, halogen, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 alkyl substituted amine, C6-C10 aryl, C1-C4 alkyl substituted C6-C10 aryl, cyano, isonitrile or phosphino, wherein the number of substitutions is from mono-to maximum number of substitutions.
2. The spiro compound according to claim 1, which is one of structures represented by formula (2) to formula (5),
Figure FDA0004078030800000012
/>
Figure FDA0004078030800000021
wherein the definitions of the rest symbols are the same as the above.
3. The spiro compound according to claim 2, which has a structure represented by formula (2) or formula (3), R 1 And R 2 The same or different.
4. The spiro compound according to claim 2, wherein L is represented by formula (2) to formula (5) 1 、L 2 、L 3 Is a single bond.
5. The spiro compound according to claim 4, which has one of the structures shown in formulas (6) to (9):
Figure FDA0004078030800000022
6. the spirocyclic compound according to claim 2, wherein ring a in said spirocyclic compound is one of the following aliphatic rings:
Figure FDA0004078030800000023
7. spirocyclic compound according to any of claims 1 to 6, R 1 And R 2 And Ar is selected from substituted or unsubstituted phenyl, biphenyl, naphthyl, fluorenyl, dibenzofuranyl or carbazolyl, wherein the substitution is by deuterium, F, cl, br, C6-C10 aryl, C1-C6 alkyl, C3-C6 cycloalkyl.
8. The spiro compound of claim 7, R 1 ,R 2 Is substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C3-C20 cycloalkyl.
9. The spiro compound according to claim 1, being one of the following structural formulae, or the corresponding partially or fully deuterated or fluorinated:
Figure FDA0004078030800000031
/>
Figure FDA0004078030800000041
/>
Figure FDA0004078030800000051
/>
Figure FDA0004078030800000061
10. use of the spiro compound according to any one of claims 1 to 9 in an organic electroluminescent device.
11. Use according to claim 10 of a spiro compound according to any of claims 1 to 9 as a hole injection layer and/or a hole transport layer in an organic electroluminescent device.
CN202310114497.9A 2023-01-12 2023-02-15 Spiro compound and application thereof Active CN115974702B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023100413959 2023-01-12
CN202310041395 2023-01-12

Publications (2)

Publication Number Publication Date
CN115974702A true CN115974702A (en) 2023-04-18
CN115974702B CN115974702B (en) 2023-12-08

Family

ID=85958232

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310114497.9A Active CN115974702B (en) 2023-01-12 2023-02-15 Spiro compound and application thereof

Country Status (1)

Country Link
CN (1) CN115974702B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024104207A1 (en) * 2022-11-14 2024-05-23 广东阿格蕾雅光电材料有限公司 Spiro compound comprising asymmetric alkyl substitution and organic light-emitting device

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111635323A (en) * 2019-06-14 2020-09-08 陕西莱特光电材料股份有限公司 Nitrogen-containing compound, electronic component, and electronic device
CN112457201A (en) * 2020-11-13 2021-03-09 阜阳欣奕华材料科技有限公司 Compound, organic electroluminescent device and display device
CN113121366A (en) * 2021-03-25 2021-07-16 陕西莱特光电材料股份有限公司 Organic compound, and electronic device and electronic apparatus using the same
CN113620917A (en) * 2021-09-09 2021-11-09 长春海谱润斯科技股份有限公司 Triarylamine compound and organic light-emitting device thereof
CN113717059A (en) * 2021-03-12 2021-11-30 陕西莱特光电材料股份有限公司 Organic compound, electronic element containing organic compound and electronic device
CN114075117A (en) * 2021-06-04 2022-02-22 陕西莱特迈思光电材料有限公司 Organic compound, and electronic element and electronic device using same
CN114195747A (en) * 2020-09-18 2022-03-18 广州华睿光电材料有限公司 Arylamine organic compounds, mixtures, compositions and organic electronic devices
CN114195654A (en) * 2020-09-18 2022-03-18 广州华睿光电材料有限公司 Arylamine organic compounds, mixtures, compositions and organic electronic devices
CN115093332A (en) * 2021-07-01 2022-09-23 四川阿格瑞新材料有限公司 Spiro compound and application thereof
US20220359832A1 (en) * 2021-02-06 2022-11-10 Beijing Summer Sprout Technology Co., Ltd. Organic electroluminescent device

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111635323A (en) * 2019-06-14 2020-09-08 陕西莱特光电材料股份有限公司 Nitrogen-containing compound, electronic component, and electronic device
WO2020248943A1 (en) * 2019-06-14 2020-12-17 陕西莱特光电材料股份有限公司 Nitrogen-containing compound, electronic component and electronic device
US11611043B1 (en) * 2019-06-14 2023-03-21 Shaanxi Lighte Optoelectronics Material Co., Ltd. Nitrogen-containing compound, electronic component and electronic device
CN114195747A (en) * 2020-09-18 2022-03-18 广州华睿光电材料有限公司 Arylamine organic compounds, mixtures, compositions and organic electronic devices
CN114195654A (en) * 2020-09-18 2022-03-18 广州华睿光电材料有限公司 Arylamine organic compounds, mixtures, compositions and organic electronic devices
CN112457201A (en) * 2020-11-13 2021-03-09 阜阳欣奕华材料科技有限公司 Compound, organic electroluminescent device and display device
US20220359832A1 (en) * 2021-02-06 2022-11-10 Beijing Summer Sprout Technology Co., Ltd. Organic electroluminescent device
CN113717059A (en) * 2021-03-12 2021-11-30 陕西莱特光电材料股份有限公司 Organic compound, electronic element containing organic compound and electronic device
CN113121366A (en) * 2021-03-25 2021-07-16 陕西莱特光电材料股份有限公司 Organic compound, and electronic device and electronic apparatus using the same
CN114075117A (en) * 2021-06-04 2022-02-22 陕西莱特迈思光电材料有限公司 Organic compound, and electronic element and electronic device using same
CN115093332A (en) * 2021-07-01 2022-09-23 四川阿格瑞新材料有限公司 Spiro compound and application thereof
CN113620917A (en) * 2021-09-09 2021-11-09 长春海谱润斯科技股份有限公司 Triarylamine compound and organic light-emitting device thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024104207A1 (en) * 2022-11-14 2024-05-23 广东阿格蕾雅光电材料有限公司 Spiro compound comprising asymmetric alkyl substitution and organic light-emitting device

Also Published As

Publication number Publication date
CN115974702B (en) 2023-12-08

Similar Documents

Publication Publication Date Title
EP3604297B1 (en) Heterocyclic compound and organic light emitting element comprising same
EP3604298B1 (en) Heterocyclic compound and organic light emitting element comprising same
JP7226718B2 (en) Organic light-emitting device, composition and film
KR102157998B1 (en) An organic electroluminescent compound and an organic electroluminescent device comprising the same
CN107709330B (en) Spiro compound and organic light-emitting element comprising same
KR20110129441A (en) Deuterated compounds for electronic applications
KR20080031808A (en) Benzofluorene compound, emission materials and organic electroluminescent device
KR20100024451A (en) Chrysenes for green luminescent applications
CN115093332B (en) Spiro compound and application thereof
CN112437770A (en) Organic light-emitting compound and organic electroluminescent element using same
CN112159412B (en) Organic nitrogen-containing heterocyclic compound and application thereof
JP2017536349A (en) Heterocyclic compound and organic light emitting device using the same
CN113039189B (en) Heterocyclic compound and organic light-emitting device comprising same
CN115974702B (en) Spiro compound and application thereof
CN112979616B (en) Benzimidazole compound and preparation method and application thereof
CN110114362B (en) Heterocyclic compound and organic light-emitting element comprising same
CN112955455B (en) Novel compound and organic light emitting device using the same
CN112739704B (en) Novel compound and organic light emitting device comprising the same
CN113831369A (en) Metal iridium complex and application thereof
WO2022116733A1 (en) Metal complex and use thereof
WO2022088853A1 (en) Organometallic compound and application thereof
CN112209944B (en) Nitrogen-containing compound, organic electroluminescent device, and electronic device
TWI843125B (en) Spiro compounds and application thereof
TWI815359B (en) An organometallic iridium compound and application thereof
KR20140080649A (en) Novel organic electroluminescence compounds and organic electroluminescence device containing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant